Deutsche Bank cut shares of Core Laboratories (NYSE:CLB) from a buy rating to a hold rating in a report issued on Thursday morning. They currently have $109.00 price objective on the oil and gas company’s stock, down from their prior price objective of $116.30.

A number of other research analysts also recently commented on the company. Royal Bank of Canada restated a buy rating on shares of Core Laboratories in a research note on Wednesday, October 18th. ABN Amro upgraded Core Laboratories from a hold rating to a buy rating in a research note on Wednesday, October 25th. Loop Capital lowered their price objective on Core Laboratories from $125.00 to $115.00 and set a buy rating for the company in a research note on Wednesday, October 25th. Scotiabank set a $136.00 price objective on Core Laboratories and gave the stock a hold rating in a research note on Wednesday, October 25th. Finally, Piper Jaffray Companies set a $97.00 price objective on Core Laboratories and gave the stock a hold rating in a research note on Monday, October 23rd. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $110.20.

Shares of Core Laboratories (NYSE CLB) traded up $0.11 during midday trading on Thursday, hitting $119.10. The stock had a trading volume of 318,200 shares, compared to its average volume of 433,022. Core Laboratories has a 1-year low of $86.55 and a 1-year high of $124.99. The company has a quick ratio of 1.81, a current ratio of 2.18 and a debt-to-equity ratio of 1.53. The company has a market cap of $5,260.00, a P/E ratio of 68.84 and a beta of 1.56.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Monday, October 23rd. The oil and gas company reported $0.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.44 by $0.04. Core Laboratories had a return on equity of 52.89% and a net margin of 12.06%. The business had revenue of $166.20 million during the quarter, compared to the consensus estimate of $160.94 million. During the same period in the previous year, the business earned $0.38 EPS. The business’s quarterly revenue was up 1.4% on a year-over-year basis. research analysts forecast that Core Laboratories will post 1.99 EPS for the current year.

A number of institutional investors and hedge funds have recently modified their holdings of CLB. Schwab Charles Investment Management Inc. grew its stake in shares of Core Laboratories by 6.7% in the second quarter. Schwab Charles Investment Management Inc. now owns 139,549 shares of the oil and gas company’s stock worth $14,133,000 after purchasing an additional 8,774 shares in the last quarter. CIBC World Markets Inc. bought a new position in shares of Core Laboratories in the second quarter worth $223,000. Eaton Vance Management grew its stake in shares of Core Laboratories by 46.4% in the second quarter. Eaton Vance Management now owns 21,852 shares of the oil and gas company’s stock worth $2,213,000 after purchasing an additional 6,924 shares in the last quarter. Alliancebernstein L.P. grew its stake in shares of Core Laboratories by 18.0% in the second quarter. Alliancebernstein L.P. now owns 2,942 shares of the oil and gas company’s stock worth $298,000 after purchasing an additional 448 shares in the last quarter. Finally, GRT Capital Partners L.L.C. bought a new position in shares of Core Laboratories in the second quarter worth $644,000.

COPYRIGHT VIOLATION NOTICE: This story was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.watchlistnews.com/deutsche-bank-lowers-core-laboratories-clb-to-hold/1808233.html.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with Analyst Ratings Network's FREE daily email newsletter.